Concepts (147)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ovary | 10 | 2009 | 961 | 2.070 |
Why?
|
| Inhibins | 3 | 2008 | 210 | 0.830 |
Why?
|
| Cisplatin | 5 | 2009 | 1654 | 0.810 |
Why?
|
| Cyclic Nucleotide-Gated Cation Channels | 3 | 2009 | 39 | 0.700 |
Why?
|
| Reproduction | 4 | 2008 | 645 | 0.660 |
Why?
|
| Gonadotropins, Equine | 2 | 2009 | 7 | 0.640 |
Why?
|
| Testicular Hormones | 2 | 2007 | 188 | 0.520 |
Why?
|
| Ion Channels | 3 | 2009 | 1044 | 0.470 |
Why?
|
| Ovarian Follicle | 4 | 2009 | 244 | 0.380 |
Why?
|
| Potassium Channels | 3 | 2009 | 534 | 0.380 |
Why?
|
| Ovulation Induction | 3 | 2009 | 276 | 0.360 |
Why?
|
| Glycoproteins | 2 | 2007 | 2196 | 0.310 |
Why?
|
| Birth Weight | 2 | 2007 | 2122 | 0.310 |
Why?
|
| Mesna | 1 | 2008 | 62 | 0.300 |
Why?
|
| Rats, Sprague-Dawley | 9 | 2009 | 8107 | 0.300 |
Why?
|
| Triplets | 1 | 2007 | 42 | 0.290 |
Why?
|
| Labor, Obstetric | 1 | 2010 | 313 | 0.280 |
Why?
|
| Pregnancy in Diabetics | 1 | 2008 | 198 | 0.270 |
Why?
|
| Ovarian Diseases | 1 | 2008 | 133 | 0.270 |
Why?
|
| Weight Gain | 2 | 2007 | 2356 | 0.270 |
Why?
|
| Rats | 11 | 2009 | 23708 | 0.250 |
Why?
|
| Twins | 1 | 2007 | 340 | 0.240 |
Why?
|
| Trial of Labor | 1 | 2006 | 85 | 0.240 |
Why?
|
| Vaginal Birth after Cesarean | 1 | 2006 | 65 | 0.240 |
Why?
|
| Anti-Mullerian Hormone | 4 | 2009 | 420 | 0.240 |
Why?
|
| Body Mass Index | 3 | 2007 | 13042 | 0.230 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2007 | 530 | 0.230 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 1 | 2007 | 658 | 0.220 |
Why?
|
| New York | 4 | 2007 | 880 | 0.220 |
Why?
|
| Personnel, Hospital | 1 | 2006 | 285 | 0.220 |
Why?
|
| Emigrants and Immigrants | 1 | 2010 | 550 | 0.220 |
Why?
|
| Luteal Cells | 1 | 2003 | 19 | 0.210 |
Why?
|
| Luteolysis | 1 | 2003 | 11 | 0.210 |
Why?
|
| Pregnancy Rate | 1 | 2006 | 654 | 0.210 |
Why?
|
| Delivery, Obstetric | 1 | 2010 | 947 | 0.210 |
Why?
|
| Apoptosis | 5 | 2009 | 9505 | 0.210 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2009 | 610 | 0.200 |
Why?
|
| Dinoprost | 1 | 2003 | 139 | 0.200 |
Why?
|
| Patient Preference | 1 | 2010 | 947 | 0.200 |
Why?
|
| Embryo Transfer | 1 | 2006 | 526 | 0.200 |
Why?
|
| Personnel Staffing and Scheduling | 1 | 2006 | 497 | 0.200 |
Why?
|
| Ovarian Cysts | 1 | 2003 | 107 | 0.200 |
Why?
|
| Fertility | 1 | 2007 | 770 | 0.190 |
Why?
|
| Staurosporine | 1 | 2003 | 240 | 0.190 |
Why?
|
| Dehydroepiandrosterone | 1 | 2003 | 248 | 0.190 |
Why?
|
| Pregnancy Outcome | 3 | 2008 | 2969 | 0.190 |
Why?
|
| Gestational Age | 2 | 2007 | 3616 | 0.190 |
Why?
|
| Hypothalamus | 1 | 2006 | 1005 | 0.180 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 2006 | 1142 | 0.180 |
Why?
|
| Infertility, Female | 1 | 2006 | 763 | 0.170 |
Why?
|
| Blotting, Western | 4 | 2008 | 5019 | 0.170 |
Why?
|
| Antioxidants | 1 | 2008 | 1671 | 0.170 |
Why?
|
| Aging | 3 | 2007 | 8725 | 0.170 |
Why?
|
| Population Surveillance | 1 | 2010 | 2596 | 0.170 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2002 | 258 | 0.160 |
Why?
|
| Estradiol | 1 | 2006 | 1947 | 0.160 |
Why?
|
| Obstetrics | 1 | 2006 | 679 | 0.150 |
Why?
|
| Infection Control | 1 | 2006 | 984 | 0.150 |
Why?
|
| Fertilization in Vitro | 1 | 2006 | 1301 | 0.150 |
Why?
|
| Horses | 2 | 2009 | 294 | 0.150 |
Why?
|
| Physician-Patient Relations | 1 | 2010 | 3270 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2007 | 3498 | 0.130 |
Why?
|
| Pregnancy | 9 | 2010 | 30230 | 0.130 |
Why?
|
| Pregnancy Complications | 2 | 2007 | 2970 | 0.130 |
Why?
|
| Body Weight | 1 | 2005 | 4627 | 0.120 |
Why?
|
| Immunohistochemistry | 4 | 2009 | 11030 | 0.120 |
Why?
|
| Mass Screening | 1 | 2008 | 5449 | 0.100 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2006 | 2470 | 0.100 |
Why?
|
| Female | 22 | 2010 | 396141 | 0.100 |
Why?
|
| Animals | 12 | 2009 | 168735 | 0.090 |
Why?
|
| Sudan | 1 | 2010 | 86 | 0.090 |
Why?
|
| Antineoplastic Agents | 3 | 2009 | 13631 | 0.090 |
Why?
|
| Somalia | 1 | 2010 | 78 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 2 | 2008 | 4563 | 0.090 |
Why?
|
| Risk Assessment | 2 | 2008 | 24275 | 0.080 |
Why?
|
| Diabetes, Gestational | 2 | 2008 | 1263 | 0.070 |
Why?
|
| Corpus Luteum | 1 | 2007 | 81 | 0.070 |
Why?
|
| Neurons | 1 | 2006 | 9527 | 0.070 |
Why?
|
| Obesity | 2 | 2007 | 13082 | 0.070 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2009 | 10727 | 0.070 |
Why?
|
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2006 | 33 | 0.070 |
Why?
|
| Eclampsia | 1 | 2007 | 61 | 0.070 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2008 | 731 | 0.060 |
Why?
|
| Overweight | 2 | 2007 | 2444 | 0.060 |
Why?
|
| Internship and Residency | 1 | 2006 | 5945 | 0.060 |
Why?
|
| Preoptic Area | 1 | 2006 | 132 | 0.060 |
Why?
|
| Maternal Age | 1 | 2008 | 804 | 0.060 |
Why?
|
| Whooping Cough | 1 | 2006 | 87 | 0.060 |
Why?
|
| Chorionic Gonadotropin | 1 | 2007 | 457 | 0.060 |
Why?
|
| Sexual Maturation | 1 | 2007 | 256 | 0.060 |
Why?
|
| Cell Line, Transformed | 1 | 2006 | 858 | 0.060 |
Why?
|
| Gene Expression | 2 | 2008 | 7581 | 0.060 |
Why?
|
| Follicular Atresia | 1 | 2003 | 7 | 0.050 |
Why?
|
| Random Allocation | 1 | 2008 | 2394 | 0.050 |
Why?
|
| Cardiolipins | 1 | 2003 | 82 | 0.050 |
Why?
|
| Oocytes | 1 | 2008 | 1168 | 0.050 |
Why?
|
| Caspase 9 | 1 | 2003 | 184 | 0.050 |
Why?
|
| RNA, Messenger | 2 | 2008 | 12768 | 0.050 |
Why?
|
| Probability | 1 | 2008 | 2474 | 0.050 |
Why?
|
| Adult | 8 | 2010 | 223088 | 0.040 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 3801 | 0.040 |
Why?
|
| Women's Health | 1 | 2010 | 2081 | 0.040 |
Why?
|
| Age Distribution | 1 | 2006 | 2864 | 0.040 |
Why?
|
| Disaster Planning | 1 | 2006 | 558 | 0.040 |
Why?
|
| Statistics as Topic | 1 | 2006 | 2350 | 0.040 |
Why?
|
| Analysis of Variance | 1 | 2008 | 6202 | 0.040 |
Why?
|
| Breast Neoplasms | 2 | 2004 | 21069 | 0.040 |
Why?
|
| Peritoneal Neoplasms | 1 | 2004 | 706 | 0.040 |
Why?
|
| Tamoxifen | 1 | 2002 | 964 | 0.030 |
Why?
|
| Pre-Eclampsia | 1 | 2007 | 1257 | 0.030 |
Why?
|
| Cross Infection | 1 | 2006 | 1426 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2003 | 1966 | 0.030 |
Why?
|
| Neoplasms, Second Primary | 1 | 2004 | 1056 | 0.030 |
Why?
|
| Humans | 11 | 2010 | 765926 | 0.030 |
Why?
|
| Androgens | 1 | 2003 | 1278 | 0.030 |
Why?
|
| Prognosis | 2 | 2008 | 29890 | 0.030 |
Why?
|
| Fetus | 1 | 2002 | 1878 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2003 | 5880 | 0.020 |
Why?
|
| Age Factors | 1 | 2008 | 18382 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2008 | 22228 | 0.020 |
Why?
|
| Neoplasm Staging | 2 | 2004 | 11196 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 15878 | 0.020 |
Why?
|
| Mitochondria | 1 | 2003 | 3669 | 0.020 |
Why?
|
| Retrospective Studies | 3 | 2007 | 81537 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2006 | 65194 | 0.020 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2002 | 2538 | 0.020 |
Why?
|
| Incidence | 1 | 2007 | 21513 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18292 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2004 | 4904 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2003 | 18962 | 0.020 |
Why?
|
| Risk Factors | 2 | 2006 | 74850 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2007 | 26380 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2010 | 54807 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2002 | 7423 | 0.010 |
Why?
|
| Mice, Inbred C57BL | 1 | 2003 | 22327 | 0.010 |
Why?
|
| Time Factors | 2 | 2004 | 40097 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 59857 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2006 | 41680 | 0.010 |
Why?
|
| United States | 1 | 2010 | 72909 | 0.010 |
Why?
|
| Genes, BRCA2 | 1 | 2004 | 591 | 0.010 |
Why?
|
| Genes, BRCA1 | 1 | 2004 | 753 | 0.010 |
Why?
|
| Mice | 1 | 2003 | 81782 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2004 | 18074 | 0.000 |
Why?
|
| Mutation | 1 | 2004 | 30192 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 59496 | 0.000 |
Why?
|
| Aged | 1 | 2004 | 171163 | 0.000 |
Why?
|
| Middle Aged | 1 | 2004 | 223016 | 0.000 |
Why?
|
Concepts
(147)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_